A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer’s disease
出版年份 2015 全文链接
标题
A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer’s disease
作者
关键词
Multiple Ascend Dose Study, Regional Cerebral Glucose Metabolism, Clinical Efficacy Measure, Clinical Efficacy Assessment, Oral AZD0530
出版物
Alzheimers Research & Therapy
Volume 7, Issue 1, Pages -
出版商
Springer Nature
发表日期
2015-03-27
DOI
10.1186/s13195-015-0119-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Fyn inhibition rescues established memory and synapse loss in Alzheimer mice
- (2015) Adam C. Kaufman et al. ANNALS OF NEUROLOGY
- Fyn kinase inhibition as a novel therapy for Alzheimer’s disease
- (2014) Haakon B Nygaard et al. Alzheimers Research & Therapy
- Current and Emerging Therapies for Alzheimer’s Disease
- (2013) Haakon B. Nygaard CLINICAL THERAPEUTICS
- Metabotropic Glutamate Receptor 5 Is a Coreceptor for Alzheimer Aβ Oligomer Bound to Cellular Prion Protein
- (2013) Ji Won Um et al. NEURON
- Effects of Src kinase inhibition by saracatinib (AZD0530) on bone turnover in advanced malignancy in a Phase I study
- (2012) Rosemary A. Hannon et al. BONE
- The Complex PrPc-Fyn Couples Human Oligomeric A with Pathological Tau Changes in Alzheimer's Disease
- (2012) M. Larson et al. JOURNAL OF NEUROSCIENCE
- Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons
- (2012) Ji Won Um et al. NATURE NEUROSCIENCE
- A neurotoxicity depends on interactions between copper ions, prion protein, and N-methyl-D-aspartate receptors
- (2012) H. You et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The cellular prion protein mediates neurotoxic signalling of β-sheet-rich conformers independent of prion replication
- (2011) Ulrike K Resenberger et al. EMBO JOURNAL
- Cellular prion protein is essential for oligomeric amyloid- -induced neuronal cell death
- (2011) W. Kudo et al. HUMAN MOLECULAR GENETICS
- Amyloid-β-induced Synapse Damage Is Mediated via Cross-linkage of Cellular Prion Proteins
- (2011) Clive Bate et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Amyloid-β42 Interacts Mainly with Insoluble Prion Protein in the Alzheimer Brain
- (2011) Wen-Quan Zou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Inhibition of Ionic Conductance in Mouse Basal Forebrain Neurons Is Dependent upon the Cellular Prion Protein PrPC
- (2011) K. Alier et al. JOURNAL OF NEUROSCIENCE
- Alzheimer's Disease Brain-Derived Amyloid- -Mediated Inhibition of LTP In Vivo Is Prevented by Immunotargeting Cellular Prion Protein
- (2011) A. E. Barry et al. JOURNAL OF NEUROSCIENCE
- Adaptation of the plasma inhibitory activity assay to detect Aurora, ABL and FLT3 kinase inhibition by AT9283 in pediatric leukemia
- (2011) Jennifer E. Podesta et al. LEUKEMIA RESEARCH
- Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites
- (2011) Darragh B. Freir et al. Nature Communications
- Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial
- (2011) François Piette et al. Alzheimers Research & Therapy
- Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an alzheimer's disease model mouse
- (2010) Erika Chung et al. BMC NEUROSCIENCE
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia: A report from the BINGO study
- (2010) Yuichi Ishikawa et al. CANCER SCIENCE
- Phase I Safety, Pharmacokinetics, and Inhibition of Src Activity Study of Saracatinib in Patients with Solid Tumors
- (2010) J. Baselga et al. CLINICAL CANCER RESEARCH
- Prion protein and Aβ-related synaptic toxicity impairment
- (2010) Anna Maria Calella et al. EMBO Molecular Medicine
- Interaction between Human Prion Protein and Amyloid-β (Aβ) Oligomers
- (2010) Shugui Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Memory Impairment in Transgenic Alzheimer Mice Requires Cellular Prion Protein
- (2010) D. A. Gimbel et al. JOURNAL OF NEUROSCIENCE
- Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: Findings from the Alzheimer's Disease Neuroimaging Initiative
- (2010) Kewei Chen et al. NEUROIMAGE
- Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy
- (2010) K. Bhaskar et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Synthetic amyloid- oligomers impair long-term memory independently of cellular prion protein
- (2010) C. Balducci et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: A randomized, double-blind, placebo-controlled, multiple-ascending-dose phase I trial
- (2009) Rosemary A Hannon et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Picomolar Amyloid- Positively Modulates Synaptic Plasticity and Memory in Hippocampus
- (2009) D. Puzzo et al. JOURNAL OF NEUROSCIENCE
- -Amyloid Monomers Are Neuroprotective
- (2009) M. L. Giuffrida et al. JOURNAL OF NEUROSCIENCE
- Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530
- (2009) Tim P. Green et al. Molecular Oncology
- Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
- (2009) Juha Laurén et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started